| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,565 |
14,190 |
$2.39M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,397 |
14,290 |
$1.72M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
10,266 |
9,252 |
$1.61M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,196 |
24,862 |
$612K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,261 |
20,531 |
$499K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,252 |
1,998 |
$402K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,577 |
4,175 |
$178K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,596 |
5,800 |
$169K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,532 |
5,115 |
$163K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,589 |
4,354 |
$150K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
486 |
448 |
$138K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
137 |
122 |
$124K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,881 |
1,727 |
$114K |
| 80053 |
Comprehensive metabolic panel |
16,741 |
14,895 |
$114K |
| J3490 |
Unclassified drugs |
36,881 |
20,961 |
$107K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,819 |
14,809 |
$104K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,796 |
1,723 |
$92K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,665 |
2,377 |
$67K |
| 71045 |
Radiologic examination, chest; single view |
2,793 |
2,455 |
$55K |
| 70450 |
Computed tomography, head or brain; without contrast material |
198 |
177 |
$42K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
600 |
509 |
$39K |
| 99205 |
Prolong outpt/office vis |
682 |
552 |
$36K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,607 |
3,272 |
$31K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
210 |
176 |
$30K |
| 71046 |
Radiologic examination, chest; 2 views |
469 |
459 |
$30K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,125 |
1,063 |
$29K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,626 |
1,456 |
$27K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
543 |
491 |
$23K |
| G0378 |
Hospital observation service, per hour |
531 |
459 |
$22K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
458 |
417 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
10,026 |
8,506 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,424 |
2,359 |
$19K |
| 81001 |
|
6,547 |
4,919 |
$18K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
57 |
51 |
$17K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
660 |
619 |
$14K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,039 |
917 |
$12K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
238 |
219 |
$12K |
| 87631 |
|
141 |
136 |
$11K |
| 83690 |
|
1,678 |
1,543 |
$10K |
| 84484 |
|
1,492 |
1,281 |
$8K |
| 84703 |
|
1,102 |
982 |
$8K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
33 |
24 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
393 |
374 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
321 |
284 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
355 |
338 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
560 |
522 |
$7K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
193 |
153 |
$6K |
| 94060 |
|
94 |
93 |
$6K |
| 43249 |
|
46 |
38 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
1,189 |
1,060 |
$5K |
| 0001A |
|
109 |
81 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
46 |
45 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
100 |
73 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
380 |
336 |
$3K |
| 0002A |
|
89 |
69 |
$3K |
| 99215 |
Prolong outpt/office vis |
281 |
271 |
$3K |
| 0012A |
|
45 |
45 |
$2K |
| 82550 |
|
827 |
742 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
513 |
471 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
40 |
36 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
13 |
13 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
278 |
248 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
52 |
51 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
57 |
43 |
$1K |
| 0011A |
|
44 |
43 |
$1K |
| 83735 |
|
229 |
191 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,019 |
921 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
55 |
51 |
$1K |
| 76801 |
|
29 |
26 |
$961.72 |
| 94760 |
|
91 |
79 |
$915.04 |
| 85730 |
|
252 |
241 |
$911.59 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
12 |
12 |
$894.40 |
| 20610 |
|
40 |
38 |
$889.71 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
25 |
24 |
$865.89 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
25 |
24 |
$849.87 |
| 94729 |
|
24 |
24 |
$841.50 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
28 |
27 |
$790.97 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
232 |
160 |
$770.78 |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
35 |
31 |
$755.40 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
27 |
26 |
$701.51 |
| 85610 |
|
260 |
243 |
$598.29 |
| 80061 |
Lipid panel |
43 |
36 |
$507.30 |
| 87807 |
|
46 |
45 |
$414.12 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
16 |
13 |
$410.27 |
| 87070 |
|
39 |
38 |
$365.33 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
116 |
108 |
$352.60 |
| 90688 |
|
96 |
92 |
$326.42 |
| 81003 |
|
147 |
135 |
$289.40 |
| A4606 |
Oxygen probe for use with oximeter device, replacement |
16 |
15 |
$283.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
31 |
27 |
$277.59 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
219 |
204 |
$259.25 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
16 |
16 |
$248.24 |
| 94726 |
|
12 |
12 |
$245.66 |
| 82607 |
|
18 |
14 |
$236.36 |
| 82570 |
|
104 |
72 |
$231.45 |
| 86850 |
|
14 |
13 |
$223.47 |
| 94010 |
|
15 |
13 |
$203.92 |
| 85027 |
|
47 |
39 |
$192.19 |
| 83880 |
|
14 |
14 |
$172.02 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
12 |
12 |
$169.42 |
| 94618 |
|
13 |
12 |
$159.41 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
193 |
162 |
$137.36 |
| 83605 |
|
20 |
15 |
$104.80 |
| 82150 |
|
12 |
12 |
$80.79 |
| A6402 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
131 |
72 |
$77.36 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
65 |
51 |
$69.38 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
42 |
40 |
$49.42 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
16 |
13 |
$37.91 |
| 86705 |
|
12 |
12 |
$32.63 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
28 |
27 |
$20.00 |
| 86704 |
|
12 |
12 |
$15.81 |
| 86706 |
|
12 |
12 |
$14.65 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
25 |
13 |
$14.45 |
| 87340 |
|
12 |
12 |
$12.82 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
15 |
12 |
$11.35 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
31 |
31 |
$2.31 |
| 91300 |
|
283 |
205 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
15 |
15 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
13 |
13 |
$0.00 |
| 80320 |
|
21 |
12 |
$0.00 |
| 91301 |
|
116 |
115 |
$0.00 |
| 87581 |
|
13 |
13 |
$0.00 |
| 87486 |
|
13 |
13 |
$0.00 |